ASCO 2021 : Cellworks Singula™ Delivers Superior OS and DFS Predictions for Brain Cancer Patients in myCare-022-03 Clinical Trial
Personalized Therapy Biosimulation Using Multi-Omic Data Accurately Predicts Clinical…
ASCO 2021 : Cellworks CBM Clinical Study Identifies Novel Biomarkers for ATRA Benefit and Failure in AML Patients
Personalized Therapy Biosimulation Predicts with 100% Accuracy ATRA Non-Response in AML…
ASCO 2021 : Cellworks Singula™ Accurately Predicts Clinical Outcome from Treatments in Patients with NSCLC
Personalized Therapy Biosimulation Using Multi-Omic Data Predicts OS and PFS for NSCLC…
ASH 2020 : Cellworks Personalized Biosimulation Clinical Trials Achieve 90% Therapy Response Prediction Accuracy for AML and MDS Patients
myCare-020-01 and myCare-020-02 studies show Cellworks Singula™ has high accuracy and…